Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Good News Network
goodnewsnetwork.org > arthritis-drug-demonstrates-substantial-hair-regrowth-in-1400-alopecia-patients

Arthritis Drug Demonstrates Substantial Hair Regrowth in 1,400 Alopecia Patients

3+ day, 10+ hour ago   (426+ words) An arthritis drug of all things was recently found in a study to restore up to 100% of hair in patients with severe alopecia. Around 2% of the world population live with alopecia areata, an autoimmune disorder where the human immune system…...

The Clinical Trial Vanguard
clinicaltrialvanguard.com > news > nektar-to-release-24-week-off-treatment-data-for-rezpegaldesleukin-in-alopecia-areata

Nektar to Release 24-Week Off-Treatment Data for Rezpegaldesleukin in Alopecia Areata

3+ day, 19+ hour ago   (323+ words) The Clinical Trial Vanguard Nektar to Release 24-Week Off-Treatment Data for Rezpegaldesleukin in Alopecia Areata Nektar Therapeutics went quiet on September 8, 2026, and will stay that way until it releases the 24-week off-treatment follow-up data from its Phase 2b REZOLVE-AA study of…...

Google News
tradingview.com > news > urn:summary_document_transcript:quartr.com:4137734:0-qttb-phase-ii-results-support-phase-iii-advancement-for-a-safe-effective-alopecia-areata-therapy

QTTB: Phase II results support phase III advancement for a safe, effective alopecia areata therapy — TradingView News

4+ day, 4+ hour ago   (75+ words) QTTB: Phase II results support phase III advancement for a safe, effective alopecia areata therapy TradingView QTTB: Phase II results support phase III advancement for a safe, effective alopecia areata therapy Positive phase II data for bempikibart in alopecia areata…...

LIGA.net
life.liga.net > en > amp > all > news > arthritis-medication-has-been-shown-to-be-effective-against-alopecia-according-to-a-study

Arthritis medication has been shown to be effective against alopecia, according to a study

5+ day, 11+ hour ago   (331+ words) Upadacitinib, an anti-inflammatory drug used to treat arthritis, has been tested as a potential treatment for alopecia areata. An international team of researchers reported the results of two Phase III clinical trials in in a magazine JAMA Dermatology. A total…...

Yahoo Finance
finance.yahoo.com > healthcare > articles > hcw-biologics-strengthens-u-patent-130000441.html

HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment

1+ week, 3+ day ago   (378+ words) HCW9302 is a best-in-class IL-2-based immunotherapeutic for treatment of autoimmune diseases through expanding and activating regulatory T cells Patent allowance received for use of HCW9302 as treatment for alopecia areata Phase 1 dose-escalating clinical study evaluating HCW9302 as monotherapy in patients with alopecia areata…...

Fortune
fortune.com > 08/29/2026 > baldness-drug-stocks-wall-street-goldmine-veradermics-absci-cosmo

Forget GLP-1 stocks, baldness drugs are Wall Street???s next goldmine

2+ week, 10+ hour ago   (603+ words) Drugmakers found a promising cure for the obesity epidemic and their stocks were rewarded for it. Now, investors are salivating over a new crop of companies tackling a more purely aesthetic problem: baldness. “People will fly all the way to…...

Google News
gilmorehealth.com > upadacitinib-restored-substantial-scalp-hair-in-severe-alopecia-areata-but-long-term-safety-and-durability-remain-unclear

Upadacitinib Restored Substantial Scalp Hair in Severe Alopecia Areata, but Long-Term Safety and Durability Remain Unclear

2+ week, 20+ hour ago   (1449+ words) Two Phase 3 trials involving 1,399 adults and adolescents found substantial scalp, eyebrow, and eyelash regrowth with upadacitinib after 24 weeks. The results are promising, but long-term safety, durability, and FDA approval for alopecia areata remain unresolved. Two randomized Phase 3 trials found that…...

Docwire News
docwirenews.com > post > upadacitinib-shows-promising-efficacy-for-alopecia-areata

Can We Add Upadacitinib to the Alopecia Areata Arsenal?

2+ week, 3+ day ago   (689+ words) Docwire News Upadacitinib Shows Promising Efficacy for Alopecia Areata According to phase 3 data, upadacitinib may represent a potential treatment option for patients with severe alopecia areata. There is currently an unmet need for systemic therapies for alopecia areata—with only…...

BlackDoctor.com
blackdoctor.com > traction-alopecia-black-children-research

What Black Parents Need to Know About Traction Alopecia — and the Research to Prevent It - BlackDoctor - Where Culture Meets Care

2+ week, 5+ day ago   (977+ words) For many Black families, doing a child’s hair is about much more than keeping it neat. Braids, cornrows, locs, twists, ponytails, and other styles can be expressions of culture, creativity, and identity. They also make caring for textured hair easier....

cureusinc
cureus.com > articles > 501507-effectiveness-of-the-dignicap-scalp-cooling-system-for-the-prevention-of-chemotherapy-induced-alopecia-an-observational-study-in-a-uruguayan-cohort

Effectiveness of the DigniCap® Scalp Cooling System for the Prevention of Chemotherapy-Induced Alopecia: An Observational Study in a Uruguayan Cohort

1+ mon, 5+ day ago   (1054+ words) Dahiana Amarillo • Natalia Camejo • Cecilia Castillo • Maria Planinich • Melanie Garcia • Belen Insagaray • Joaquin Manzanares • Belen Acevedo • Sofia Benavides • Juliana Manzino • Paola Muiño • Guillermina Servetto • Maria Guerrina • Virginia Suaya • Catherine Mate • Gabriela Latorraca • Gabriel Krygier Cite this article as: Amarillo D,…...